부산대학교 도서관

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.bbrc.2005.06.198 Byline: Ying Yu (a), Stuart A. Ross (a)(b), Amy E. Halseth (a)(c), Paul W. Hollenbach (a)(d), Ronald J. Hill (a)(e), Eric A. Gulve (a), Brian R. Bond (a) Keywords: PYK2; Knockout; Obesity Abstract: Non-receptor proline-rich tyrosine kinase-2 (PYK2), which is activated by phosphorylation of one or more of its tyrosine residues, has been implicated in the regulation of GLUT4 glucose transporter translocation and glucose transport. Some data favor a positive role of PYK2 in stimulating glucose transport, whereas other studies suggest that PYK2 may participate in the induction of insulin resistance. To ascertain the importance of PYK2 in the setting of obesity and insulin resistance, we (1) evaluated the regulation of PYK2 in mice fed a high-fat diet and (2) characterized body and glucose homeostasis in wild type (WT) and PYK2.sup.(-/-) mice on different diets. We found that both PYK2 expression and phosphorylation were significantly increased in liver and adipose tissues harvested from high-fat diet fed mice. Wild type and PYK2.sup.(-/-) mice were fed a high-fat diet for 8 weeks to induce insulin resistance/obesity. Surprisingly, in response to this diet PYK2.sup.(-/-) mice gained significantly more weight than WT mice (18.7[+ or -]1.2g vs. 9.5[+ or -]0.6g). Fasting serum leptin and insulin and blood glucose levels were significantly increased in high-fat diet fed mice irrespective of the presence of PYK2 protein. There was a close correlation between serum leptin and body weight. Intraperitoneal glucose tolerance tests revealed that as expected, the high-fat diet resulted in increased blood glucose levels following glucose administration in wild type mice compared to those fed normal chow. An even greater increase in blood glucose levels was observed in PYK2.sup.(-/-) mice compared to wild type mice. These results demonstrate that a lack of PYK2 exacerbates weight gain and development of glucose intolerance/insulin resistance induced by a high-fat diet, suggesting that PYK2 may play a role in slowing the development of obesity, insulin resistance, and/or frank diabetes. Author Affiliation: (a) PFIZER Global Research and Development, Cardiovascular Pharmacology, 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA (b) Institute for Diabetes Discovery, 23 Business Park Drive, Branford, CT 06405, USA (c) Amylin Pharmaceuticals, Inc., 9360 Towne Center Drive, San Diego, CA 92121, USA (d) Chiron Corporation, 4560 Horton St., Emeryville, CA 94608-2916, USA (e) Roche Pharmaceuticals, 3431 Hillview Ave., Palo Alto, CA 94304, USA Article History: Received 17 June 2005